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a  b  s  t  r  a  c  t
Chronic  exposure  to  solar  radiation  could  contribute  to  premature  skin  aging  and skin  cancer.  Skin
presents  its own  antioxidant  defense,  however  when  defenses  are  out  of balance,  reactive  oxygen  species
could damage  biological  structures.  In  the present  work,  an  oil-in-water  photoprotective  emulsion  was
developed  and Bauhinia  microstachya  var.  massambabensis  Vaz,  Fabaceae,  extracts  at 1%  (obtained  by
extraction  with  different  solvents)  were  added  to this  emulsion.  In vitro  and  in  vivo  efﬁcacy  and  safety  of
the formulations  were  evaluated.  Spectrophotometric  methods  and  in  vivo  Colipa  test were  performed
to  evaluated  efﬁcacy  of  the  formulations,  through  sun  protection  factor  (SPF)  determination  and  UVA
protection  factor  assessment.  To the  in  vitro  safety  assessment  HET-CAM,  CAM-TBS  and Red  Blood  Cell
tests  were  performed.  Results  showed  that  both  extracts  contributed  to  a  higher  in  vivo  photoprotectionvaluation methods (SPF  18)  when  compared  to  the formulation  without  extract  (SPF  13),  this  result  could be  attributed  to  the
antioxidant  activity  of the  plant  extracts  that  act by capturing  reactive  oxygen  species.  Concerning  safety,
all formulations  were  considered  non-irritant  according  to in  vitro  tests.  Formulations  containing  extracts
could be considered  efﬁcient  and  safe  for cosmetic  use  since  they  presented  higher  sun protection  factor
and  passed  the toxicity  tests.
© 2016 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Skin is the outer covering of human body conferring protection
gainst ultraviolet (UV) radiation (Bouwstra et al., 2007; Bolzinger
t al., 2012). However, chronic exposure to UV radiation leads to
any side effects to the skin, such as premature aging, skin can-
er and reduction of immune response capability. These health
roblems are directly related to the formation of reactive oxygen
pecies (ROS) by UV radiation (Jain and Jain, 2010; Gilbert et al.,
013).
Even presenting antioxidant defense mechanisms, skin could
e affected by ROS; when defense mechanisms are out of balance,
xidative stress could damage cellular membranes, proteins, car-
ohydrates and nucleic acids promoting their oxidation (Finkel
∗ Corresponding author.
E-mail: mariacristinareis@micro.ufrj.br (M.C.P.P. Reis Mansur).
http://dx.doi.org/10.1016/j.bjp.2015.11.006
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraand Holbrook, 2000; Gálvez, 2010). On the other hand, ROS play
in vivo positive functions related to energy production, phagocyto-
sis, cell growth regulation and intercellular signaling (Gutteridge
and Halliwell, 2000; Rouanet et al., 2010).
Inorganic and organic sunscreens are added to photopro-
tective formulations since they act protecting the skin against
UV radiation; however, recently there has been much research
about the use of antioxidants extracted from plants. These natural
antioxidants usually come from a diet rich in fruits and vegetables
or they are carried in creams and topically applied (Podda and
Grundmann-Kollmann, 2001). Plant extracts with antioxidant
properties raise great interest in the phytocosmetic ﬁeld as they
present molecules that could inactivate ROS restoring skin home-
ostasis thus preventing erythema and premature aging of the skin
(Calderon-Montano et al., 2011; Mansur et al., 2012). Barradas and
coworkers (2014) developed nanoemulsions containing plant oil,
sweet fennel oil, to be applied topically; the researchers veriﬁed
that sweet fennel oil presented antioxidant properties, probably
 Ltda. All rights reserved.
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ue to the presence of ﬂavonoids and terpenoids that promote
igh radical scavenging activity.
In a previous work from our group, it was studied the antiox-
dant effect of different plant extracts from the genus Bauhinia
Mansur et al., 2012). B. microstachya var. massambabensis Vaz,
abaceae, is restricted to arid zones and it is found only in Rio de
aneiro State, Brazil.
Our study has demonstrated a higher antioxidant activity of
auhinia leaf extract when compared to the Gingko biloba standard
xtract (EGb 761) and Trolox® (a vitamin E water-soluble analog).
auhinia plant extracts present high amounts of ﬂavonoid glyco-
ides, including galloyl derivatives, as well as methyl gallate and
allic acid-like substances that are acknowledged as potent antiox-
dants thus being a source for the study of different pharmacologic
ctivities and did not show phototoxicity according to the Minimal
nhibitory Concentration Method (MIC), where no zone of inhibi-
ion in the growth of in the Saccharomyces cerevisiae was veriﬁed
Mansur et al., 2012).
The main substances and their molecular structures identiﬁed
n the phytochemical fractionation of Bauhinia ethyl acetate
xtract are the ﬂavonoids kaempferol-3-O-rhamnoside (1) and
stragalin-2′′,6′′-di-O-digallate (2) (Mansur et al., 2012). Other
uthors also identiﬁed these ﬂavonoids in Bauhinia active plant
xtracts (Menezes et al., 2004; Silva et al., 2007).
Flavonoids generally occur in plants as glycosylated derivatives
hat participate in photosynthesis (Pietta, 2000). These phenolic
ompounds confer protection to the plants since they capture ROS,
rotecting them from oxidation, which is generated by UV radiation
rom the sun. For this reason, these compounds could be topically
pplied on humans with the same intention of capturing ROS, thus
nhibiting lipid peroxidation, which is responsible for skin aging
nd skin cancer (Zuanazzi and Montanha, 2004; Laguerre et al.,
007).
In recent years, natural substances have been increasingly
ncorporated into dermocosmetic formulations; it is a world-
ide tendency to add value to products especially because of the
reat commercial appeal and increased acceptance by customers.
esides, the development of photoprotective formulations using
ess synthetic sunscreens is one of the objectives in photoprotection
esearch (Gilaberte and González, 2010; Hayes et al., 2011). How-
ver, the safety of these formulas must be evaluated before their
vailability to customers; thus the irritant potential of photopro-
ective formulations should be assessed through in vitro and in vivo
ests to guarantee the presence of safer products in the market,
educing risks to costumers (Anvisa, 2012).Many in vitro tests are available to evaluate toxicity of cosmetic
roducts; some of which are destined to evaluate ocular toxicity,
.g. Hen’s Egg Chorioallantoic Membrane (HET-CAM) test, Chorioal-
antoic Membrane-Trypan Blue Staining (CAM-TBS) test, Red Blood de Farmacognosia 26 (2016) 251–258
Cell (RBC) test and Bovine Corneal Opacity and Permeability (BCOP)
test (Anvisa, 2012). These tests aim to evaluate the safety of facial
cosmetic products, since the product could be easily in contact
with the eye mucous membrane generating irritation. Moreover,
toxicity tests could be also performed to evaluate primary cuta-
neous irritation, which is necessary when it comes to topical
formulations.
The aim of the present study was to develop photopro-
tective oil-in-water (O/W) emulsions containing the sunscreens
benzophenone-3 (BZF-3), octylmethoxycinnamate (OMC) and
octocrylene (OCT) and Bauhinia microstachya var. massambaben-
sis Vaz leaf extracts – in water and acetone (WAc) and in ethanol
treated with activated carbon (EtOH-AC) – and evaluate the in vivo
efﬁcacy and safety of these formulations.
Materials and methods
Chemicals
All reagents were of analytical grade (Sigma, Merck). Sunscreens
used in the formulations: BZF-3, purchased from Galena (Brazil);
OMC, purchased from Spectrum (Brazil) and OCT, purchased from
DEG (Brazil).
Plant leaf extracts
Bauhinia microstachya var. massambabensis Vaz, Fabaceae,
leaves were collected from the botanical garden of the Department
of Botany and Pharmacognosy (Federal University of Rio de Janeiro)
and the leaf extracts were obtained according to the Management
Council for Brazililan Genetic Patrimony (CGEN), resolutions n◦ 28
and n◦ 29, 2007. The specimen was  deposited under the number
30813 in the Herbarium of the Biology Institute of the Federal Uni-
versity of Rio de Janeiro, a CGEN-accredited Herbarium RFA. Extracts
were obtained according to Mansur and coworkers (2012) – in
water and acetone (WAc) and in ethanol submitted to treatment
with activated carbon to provide a less colored ethanol extract
(EtOH-AC). These extracts were chosen since they are more suit-
able to cosmetic application than the other extracts obtained by
the group in a previous work (Mansur et al., 2012). Sunscreens used
in the formulations: BZF-3, purchased from Galena (Brazil); OMC,
purchased from Spectrum (Brazil) and OCT, purchased from DEG
(Brazil).Development of the formulations
The ingredients used to the development of the formulations
are listed in Table 1. It was developed four O/W emulsions: with
M.C.P.P. Reis Mansur et al. / Revista Brasileira de Farmacognosia 26 (2016) 251–258 253
Table  1
Composition of the formulations A, B, C, D and E.
Ingredients Formulations
A B C D E
Oil phase (wt%)
BZF-3 5 5 5 – –
OCT  5 5 5 – –
OMC  5 5 5 – –
Cetostearyl alcohol ethoxylate 3 3 3 3 3
Stearic acid 8 8 8 8 8
Isoctyl stearate 7 7 7 7 7
Glyceryl monostearate 3 3 3 3 3
Propylparaben 0.1 0.1 0.1 0.1 0.1
Dimethicone copolyol 9.5 9.5 9.5 9.5 9.5
Cyclomethicone 11 11 11 11 11
Aqueous phase (wt%)
Aminomethyl propanol 95% 0.3 0.3 0.3 0.3 0.3
Glycerin 5 5 5 5 5
Imidazolidinyl urea 0.2 0.2 0.2 0.2 0.2
Methylparaben 0.1 0.1 0.1 0.1 0.1
Hydroxypropyl starch phosphate 1 1 1 1 1
EtOH-AC extract – 1 grams – 1 grams –
WAc  extract – – 1 grams – 1 grams
00 wt% Qsa 100 wt%  Qsa 100 wt% Qsa 100 wt%
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Table 2
Correlation between the erythemogenic effect (EE) and the radiation intensity at
each wavelength (I) (Mansur et al., 1986).
 (nm) EE () × I ()
290 0.0150
295 0.0817
300 0.2874
305 0.3278
310 0.1864Puriﬁed water Qsa 100 wt%  Qsa 1
a Qsf: quantity sufﬁcient.
he mixture of the three sunscreens, BZF-3, OMC  and OCT (for-
ulation A); with the same mixture of sunscreens and 1 wt% of
tOH-AC extract (formulation B) and with the same mixture of
unscreens and 1 wt% of WAc  extract (formulation C). In addi-
ion, it was also prepared O/W emulsions containing only one
xtract, without sunscreens: formulation D with 1 wt%  of EtOH-
C extract and formulation E with 1 wt% of WAc  extract to verify
f the Bauhinia extracts alone (without sunscreens) presented sun
rotection (in vitro SPF assessment).
The standard O/W emulsion (without sunscreens or extracts)
as a typical white-colored formulation with pH of 6.0 that was
roduced by the classical emulsiﬁcation method where the oil
hase is heated and poured into the aqueous phase at the same
emperature (around 70 ◦C) under slow stirring until complete
omogenization; the emulsiﬁer enable the interaction of both
hases. To formulation A, B and C, sunscreens were solubilized in
he oil phase before the mixture with the aqueous phase and to for-
ulations B, C, D and E the respective extracts were added after the
hases’ mixture, under slow stirring when the temperature was at
0 ◦C to prevent the extracts’ degradation by heat.
n vitro SPF and UVA Protection Factor (UVA-PF) assessment
In vitro SPF evaluation is usually performed to estimate the
n vivo SPF. To the in vitro SPF assessment formulations A, B, C, D
nd E were evaluated.
Samples were diluted in ethanol at a ﬁnal concentration of
 l/ml and analyzed by UV spectrophotometry (Jasco V-630) from
90 to 320 nm,  with intervals of 5 nm,  according to Mansur’s
ethod (1986) (Mansur et al., 1986). Mansur’s method is simple
nd easily reproducible, the SPF determination which is the cor-
elation between the erythemogenic effect (EE) and the radiation
ntensity at each wavelength (I) (Table 2) and are adjusted accord-
ng to Eq. (1). Where the correction factor (CF) is 10, EE () is
he erythemogenic effect of radiation on wavelength , I() is the
ntensity of solar light with wavelength  and abs () is the sam-
le (2 l/ml in ethanol) spectrophotometric absorbance value at
avelength .
pectrophotometric SPF = CF
∑320
290
EE()I()abs() (1)315 0.0839
320 0.0180
To the in vitro UVA-PF assessment it was  used a UV transmittance
analyzer (Labsphere® UV-2000S) and quartz plates with an area
of 25 cm2. The plates were covered by TransporeTM tape on one
surface and an amount of 50 mg  (2 mg/cm2) of each formulation
was applied with a micropipette on this surface and manually
spread with circular movements in order to obtain a homoge-
neous ﬁlm. Glycerin was  used as reference for 100% of transmission
(Labsphere, 2008). After drying for 15 min in dark chamber, sam-
ples were analyzed. Both assays were performed in triplicate and
the mean ± standard deviation (SD) was  assessed.
Photostability assay
Formulations A, B and C were evaluated in the photostability
assay. The assay was performed using a solar simulator (Oriel
91192-1000), a UV spectrophotometry (Jasco V-630) and a UV
transmittance analyzer (Labsphere® UV-2000S). To the SPF
assessment (Mansur’s method), the amount of 250 mg  of each
formulation was  applied to 30 mm diameter Petri dishes with 1 ml
of ethanol forming a homogeneous ﬁlm. The plates dried in a dark
chamber for 60 min  to allow ethanol to evaporate. For UVA-PF
assessment, the samples were applied in quartz plates covered by
TransporeTM tape. All plates and Petri dishes were irradiated for
90 min  in the solar simulator with radiation intensity of 315 J/m2/s
(UVA) and 3.35 J/m2/s (UVB). Three plates and three Petri dishes
were stored in the absence of light without being irradiated, as a
negative control. After irradiation, samples were diluted in ethanol
and analyzed by UV spectrophotometry according to Mansur’s
method (SPF) or analyzed in the UV transmittance analyzer
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distilled water. The denaturation index obtained are comparable54 M.C.P.P. Reis Mansur et al. / Revista Bra
UVA-PF). The test was performed in triplicate and the mean ± SD
as assessed.
n vivo SPF assessment
To the in vivo SPF assessment formulations A, B and C were
valuated. This assay was  carried out according to the Brazilian
thics Committee for Clinical Trials (number: 120/10/2011). The
ethodology employed was based on the International Sun Pro-
ection Factor Test Method developed by Colipa and published as a
uideline in 2006 (Colipa, 2006).
The SPF value is deﬁned as the ratio between the ultraviolet
nergy required to produce a minimal erythemal dose (MED) on
rotected skin and the ultraviolet energy required to produce a
ED  on unprotected skin according to Eq. (2).
PF = MED  of protected skin
MED  of unprotected skin
(2)
en women between the ages of 18 and 42 years with skin pho-
otypes I, II or III (Fitzpatrick, 1975) were selected as volunteers
fter being informed about the study protocols and agreed to par-
icipate giving their written consent. The back of each volunteer
as exposed to ultraviolet radiation using a multiport (model
01) ultraviolet solar simulator. The exposure time was  changed
ccording to skin phototype. On the second day the MED  (without
unscreen) was assessed for each volunteer and then the formula-
ions B, C and D were applied in the amount of 2 mg/cm2 to other
reas on the back of the volunteer. After the application, the prod-
cts were left to dry for 15 min  before being irradiated. Areas of
 × 6 cm were irradiated in six points with increasing UV radiation
oses. The SPF for each formulation was assessed as a mean ± SD of
he SPF values obtained for the volunteers.
afety of the photoprotective formulations and extracts: irritant
otential evaluation
Formulations A, B and C were evaluated regarding their safety
Anvisa, 2012). In addition, to verify the safety of the free extracts
without being incorporated into the O/W emulsion), they were
ehiculated at 1 wt% in phosphate buffer (PB) pH 7.4. Three different
ethods were performed: HET-CAM test, CAM-TBS test and RBC
est.
en’s Egg Chorioallantoic Membrane (HET-CAM) test
Chicken embryos have been widely used as an alternative to the
n vivo ocular irritation test. For this test, fresh fertile Leghorn eggs
eighing 50–60 g were placed in an automatic rotation incubator
nd kept at 37.5 ± 0.5 ◦C with relative humidity of 62.5 ± 7.5% dur-
ng 10 days. On the tenth day, the egg shell around the air chamber
as removed using an odontological saw, exposing the shell mem-
rane that was moistened with saline solution 0.9%. With the aid of
weezers the shell membrane was removed exposing the chorioal-
antoic membrane (CAM). Visual analysis was performed to verify
f the CAM was suitable to the test then 300 l of each formula-
ion was placed on the CAM surface. After 20 s, the formulation
as removed with saline solution. The CAM was observed under a
agnifying glass for 5 min  to determine the incidence of any irritant
ffects in the CAM blood vessels (hyperemia, hemorrhage or coagu-
ation) (Luepke and Kemper, 1986; Worth and Balls, 2001; Liebsch
nd Spielman, 2002). The irritant effects were classiﬁed by scores (1,
, 5, 7, or 9) according to the time they were observed: less than 30 s
hyperemia: 5; hemorrhage: 7; clot formation/opacity: 9); between
0 and 120 s (hyperemia: 3; hemorrhage: 5; clot formation/opacity:
); or between 120 and 300 s (hyperemia: 1; hemorrhage: 3; clot de Farmacognosia 26 (2016) 251–258
formation/opacity: 5). If an effect was  not observed after 5 min, it
was scored as zero.
Each formulation was  classiﬁed according to the scores mean
value of four eggs: 0–4.99 corresponding to non-irritant/slightly
irritant (NOI/SLI); 5.00–8.99 corresponding to moderately irritant
(MOI); and 9.00–21.00 corresponding to severely irritant (SEI). As a
negative control four eggs were submitted to the same procedure,
but no formulation was added.
Chorioallantoic Membrane-Trypan Blue Staining (CAM-TBS) test
CAM-TBS is a quantitative method for the evaluation of the
formulations’ toxicity (Invitox, 1996; Lagarto et al., 2006). The
CAM-TBS test uses trypan blue as an indicator of chorioallantoic
membrane (CAM) injury and shows a good correlation with the in
vivo Draize eye irritation test (Liebsch and Spielman, 2002; Scott
et al., 2010). The methodology is similar to the HET-CAM and after
the removal of the cosmetic formulation, 500 l of a phosphate
saline buffer and 0.1% of trypan blue staining (TBS) were added to
the CAM in the area limited by a 18 mm diameter silicone ring. The
excess of TBS was  rinsed off with distilled water, and the CAM area
that was  limited by the silicone ring was removed with scissors
and put into 5 ml  of formamide and then agitated and centrifuged.
The absorbance of the supernatant was  measured by spectropho-
tometry at 595 nm.  The quantiﬁcation of the trypan blue staining
that entered the cells could be correlated to the injury caused by
the formulation to the CAM.
Each formulation was  classiﬁed according to the mean value of
four eggs based on the HET-CAM scores: 0–4.99 corresponding to
NOI/SLI; 5.00–8.99 corresponding to MOI; and 9.00–21.00 corre-
sponding to SEI. The score (d) for each formulation was assessed
using Eq. (3) (Lagarto et al., 2006). As a negative control four eggs
were submitted to the same procedure, but no formulation was
added.
TBS concentration = d × 5
1000
× 109 nmol (3)
Red blood cell (RBC) test
RBC test enables the quantiﬁcation and evaluation of the side
effects caused by surfactants added to many cosmetic products,
such as shampoo, shower gel and emulsions in the red blood cells
plasmatic membrane and consequently the hemoglobin release
(hemolysis) and the hemoglobin denaturation index, both quan-
tiﬁed by spectrophotometry. The relationship between hemolysis
and hemoglobin oxidation provides a parameter to the characteri-
zation of the in vitro irritant effects of the surfactants (Alves et al.,
2008).
Sheep RBC were isolated by g force. For hemolysis analysis, solu-
tions of 1 mg/ml  of each formulation in PBS were added to vials in
order to create a range of increasing concentrations to enable lin-
ear regression. Their volume was ﬁlled up to 975 l with PBS and it
was added 25 l of RBC suspension with a well-known concentra-
tion of oxyhemoglobin. The resulting suspension was incubated for
10 min  at room temperature under slow stirring. After 10 min  the
samples were centrifuged at 10,000 × g for 1 min. The absorbance of
the supernatant was determined by spectrophotometry at 540 nm
(for oxyhemoglobin) and at 575 nm (for deoxyhemoglobin). For a
0% hemolysis control, 25 l of RBCs was  added to 975 l of PBS, and
for a 100% hemolysis control, 25 l of RBC was  added to 975 l ofto the in vivo ocular irritant effect: >100 corresponding to NOI; >10
corresponding to SLI; >1 corresponding to MOI; >0.1 corresponding
to irritant (I); and <0.1 corresponding to SEI. The test was performed
in triplicate.
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Table  3
In vitro assessment of the SPF and the UVA-PF of the formulations A, B, C, D and E before and after irradiation for formulations that presented photoprotective activity.
Formulations SPFa SPF after irradiationa UVA-PFa UVA-PF after irradiationa
A 17.0 ± 0.25 16.6 ± 0.22 2.63 ± 0.17 2.50 ± 0.16
B  17.8 ± 0.77 16.4 ± 0.01 2.50 ± 0.10 2.40 ± 0.20
C  16.9 ± 0.62 16.6 ± 0.13 2.45 ± 0.10 2.40 ± 0.20
D  0.70 ± 0.06 They were not considered photoprotective
formulations since SPF in too lowE  0.68 ± 0.02
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enging activity of the antioxidant molecules present in the plant
extracts that act by capturing ROS.
All formulations presented a suitable SPF but the extracts con-
tributed to the enhancement of in vivo SPF. The higher in vivo SPF of
13.48
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*
*a Mean ± SD.
tatistical analysis
Experimental data are presented as the mean ± SD with at least
hree determinations for independent experiments. All data were
nalyzed by paired and unpaired t-tests using Origin 8.5.1 (Origin-
ab, USA) software and p < 0.05 was considered to be statistically
igniﬁcant.
esults and discussion
evelopment of the formulations
The formulations A, B, C, D and E were successfully obtained. All
ormulations presented a visual aspect and texture suitable to be
pplied topically.
n vitro assessment of SPF and UVA-PF before and after irradiation
photostability assay)
Table 3 shows the results of the in vitro SPF for formulations A,
, C, D and E.
Formulations containing only sunscreens (A) and sunscreens
nd extract (B and C) presented in vitro SPF suitable to photopro-
ective products. Formulations D and E did not present SPF, for this
eason they were not considered photoprotective formulations,
hus they were not evaluated in terms of UVA-PF and photosta-
ility (Santos et al., 1999; Freitas et al., 2001; Monteiro et al., 2012;
ota et al., 2013).
Even not contributing with the in vitro SPF, both extracts present
henolic compounds that could act preventing UV-induced damage
y other mechanisms, e.g.  capturing and inactivating ROS (Greul
t al., 2002).
The addition of EtOH-AC and WAc  Bauhinia extracts did not
nﬂuence sunscreens’ photostability since there was no statistical
ifference among in vitro SPF and UVA-PF (p > 0.05). On the other
and, extracts did not contribute to sunscreens photodegradation
hen exposed to UV radiation.
The photodegradation of sunscreens generates ROS that can
amage skin structures (Butt and Christensen, 2000) and an
ntioxidant plant extract added to the formulation could act
y capturing these reactive species and increasing sunscreens
hotostability (Jarzycka et al., 2013; Cerqueira-Coutinho et al.,
015). Cerqueira-Coutinho and co-workers (2015) found out that
he addition of pomegranate extract to a photoprotective for-
ulation increased sunscreens photostability, since the plant
xtract presented high antioxidant activity according to DPPH•
2,2-diphenyl-1-picrylhydrazyl) assay (described as EC50 – half
aximal effective concentration).
In our previous study (Mansur et al., 2012), DPPH• free radical
ssay was performed to evaluate the antioxidant potential of the
solated compounds. DPPH• free radical assay does not take into
ccount the formulation where the compound was vehiculated.
his as a limitation of the DPPH• assay since the active substance
ust be solubilized in a solvent, commonly an organic one. Themeasurements are performed in a spectrophotometer and for this
reason the sample must be completely solubilized. The other com-
ponents present in the formulation such as waxes and other oily
materials that constitute the emulsion where the extracts were
vehiculated, could interfere in the measurements and for this rea-
son for this test, the active is evaluated alone (Blois, 2002; Boonne
and Yotsawimonwat, 2011; Faudale et al., 2008; Oktay et al., 2003;
Piccaglia and Marotti, 2001; Ruberto et al., 2000; Salama et al.,
2013). The ability to scavenge DPPH• radical was  measured by
the discoloration of the solutions prepared in this experiment,
using spectrophotometry. The greater the antioxidant activity
the higher the intensity of solution discoloration (Mensor et al.,
2008).
In vivo SPF assessment
Formulation A, without plant extract presented the lowest SPF,
13.48 ± 1.99 while formulations B and C, both containing plant
extract, presented SPF of 18.98 ± 3.30 and 17.90 ± 3.35, respectively
(Fig. 1). No statistical differences were obtained for comparisons
between the SPF of formulations B and C (p > 0.05). On the other
hand, the SPF of formulation A was statically lower than the SPF of
formulations B and C (p < 0.05).
All formulations presented a suitable SPF but the extracts con-
tributed to the enhancement of in vitro SPF. The higher in vivo SPF of
formulations B and C (with antioxidant extracts) when compared
to formulation A (without extract) could be attributed to the scav-Formulations
Fig. 1. Comparison among SPF of the formulations containing plant extract and the
formulation containing sunscreens only. * Signiﬁcantly different from formulation
A  (p < 0.05).
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Table 4
HET-CAM, CAM-TBS and RBC results for formulations and pure extracts (1 wt% in PB pH 7.4) with their classiﬁcation based on the irritant effects and denaturation index.
Formulations HET-CAM CAM-TBS RBC Classiﬁcation
Scorea Scorea Lisys/denaturation index
A 1.92 ± 0.38 4.59 ± 0.24 >100 NOI/SLI
B  2.13 ± 0.88 4.53 ± 0.42 >100 NOI/SLI
EtOH-AC 1 wt%  in PB 2.25 ± 1.06 3.09 ± 0.38 >100 NOI/SLI
C  2.0 ± 0.71 4.48 ± 0.31 >100 NOI/SLI
WAc  1 wt%  in PB 0 1.07 ± 0.64 >100 NOI/SLI
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ormulations B and C (with antioxidant extracts) when compared
o formulation A (without extract) could be attributed to the scav-
nging activity of the antioxidant molecules present in the plant
xtracts that act by capturing ROS. It is suggested that the solvent
sed in the extraction (WAc and EtOH-AC) did not inﬂuence on the
ntioxidant activity.
The plant extracts evaluated in this work did not absorb in the
V part of the spectrum. However, the role of the plant extract in
he formulation is to indirectly enhance in vivo SPF. ROS are pro-
uced by UV radiation and are responsible to the skin erythema
ppearance, consequently when ROS are inactivated by antioxidant
olecules, in vivo SPF tends to rise as it is assessed based on the
ppearance of skin erythema (Gilaberte and González, 2010). For
his reason it is suggested that the higher photoprotective capacity
f the formulations containing the extracts revealed the antioxi-
ant potential of the extracts, already conﬁrmed in our previous
ork (Mansur et al., 2012).
In addition, one of the goals of the photoprotection research
s to decrease the concentration of synthetic sunscreens added in
hotoprotective formulations since these organic molecules in high
oncentrations could promote skin irritation (Morabito et al., 2011;
ambandan and Ratner, 2011; Chen et al., 2012; Jansen et al., 2013).
or this reason, plant extracts could be added to photoprotective
ormulations enabling a reduction in sunscreens’ concentration but
eeping the same in vivo SPF.
Studies related to oral uptake or topical application of plant
erivatives having antioxidant components showed that these sub-
tances could protect the skin against ROS, avoiding premature
kin aging and free radical-related diseases. For example, studies
ave demonstrated that regular application of an emulsion con-
aining hyperforin reduced free radical formation and stabilized
he lipids that constitute the skin barrier (Meinke et al., 2012,
013; Haag et al., 2014). In the in vitro experiment, SPF results for
ormulations A, B and C were not statically different; all formu-
ations presented a SPF around 17. However, when compared to
he in vitro experiment, the in vivo SPF for formulation A was  the
owest one (13.48 ± 1.99). It could occur since in vivo testing often
resents biological factors that have to be taken into consideration.
ven presenting a good in vitro correlation, only the in vivo test
s accepted to register a photoprotective formulation in a health
are regulatory agency for commercial purposes. In vitro SPF tests
re usually performed as a screening to select the best formula-
ions and then the next step is in vivo testing (Vergnanini et al.,
999).
en’s Egg Chorioallantoic Membrane (HET-CAM) test and
horioallantoic Membrane-Trypan Blue Staining (CAM-TBS) test
The results of HET-CAM and CAM-TBS tests are showed in
able 4. According to the classiﬁcation by scores, for both tests
he formulations were classiﬁed as non-irritant/slightly irritant
NOI/SLI), suggesting that they are safe to be applied on the
kin.WAc  extract vehiculated at 1 wt% in phosphate buffer (PB)
pH 7.4 showed the lowest score in HET-CAM and CAM-TBS tests,
indicating that the extract alone (without being vehiculated in a
cosmetic formulation) is not a potential irritant.
Both tests are related to ocular irritation, which can be associ-
ated to cosmetic application on the face, near to the ocular mucous
membrane.
HET-CAM and CAM-TBS classiﬁcation requires a comparison
with RBC assay, to conﬁrm that the formulation is not toxic since
the aim is to obtain data related to vascularization (HET-CAM) and
cytotoxicity (RBC) to evaluate ocular irritation potential. Since skin
irritation starts with vascular alterations (Hyperemia) and HET-
CAM alterations is based upon vascular effects on the CAM, the non
observation of these effects may  suggest that formulation possess
also a lower skin irritation potential.
Nascimento and co-workers (2012) also found that sunscreens
encapsulated in polymeric nanocapsules did not present irritant
potential, which corroborate our results.
Red blood cell (RBC) test
The results to the RBC test are showed in Table 4. All formu-
lations were classiﬁed as non-irritant/slightly irritant (NOI/SLI),
which conﬁrm the previous in vitro safety tests (HET-CAM and
CAM-TBS).
Conclusions
Bauhinia microstachya var. massambabensis leaf extracts (EtOH-
AC and WAc) were successfully incorporated into O/W emulsions
containing sunscreens. The photoprotective formulations con-
taining extracts were photostable after irradiation in the solar
simulator, thus the extracts did not contribute to sunscreen’s
photodegradation when exposed to UV radiation. Concerning the
efﬁcacy tests, all formulations presented a suitable SPF and both
plant extracts contributed to a higher photoprotective effect, as an
enhancement in the in vivo SPF, when the extracts were added to
the formulations. It is suggested that plant extracts acted by cap-
turing ROS, thus minimizing erythema and collaborating indirectly
to in vivo SPF enhancement. Both formulations could be considered
safe for cosmetic use since they passed the toxicity tests, demon-
strating that they are not irritant to the eyes and skin.
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